Piramal Pharma Limited Announces Results for Q1 FY27
MUMBAI, India, July 30, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the First Quarter (Q1)...